China Biologic Products
Data Breaches, Cyber Attacks and Security Report
https://chinabiologic.com ᛫
Last updated January 29, 2020
https://chinabiologic.com ᛫
Last updated January 29, 2020
China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is the only blood plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province in China with a population of 93 million. The company is engaged in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely China Biologic Products is implementing good security practices.
{{ passedCheck.passTitle }}
{{ failedCheck.failTitle }}Read more about the latest issues in cybersecurity
Compare China Biologic Products's security performance with other companies